GENTILE, Ivan
 Distribuzione geografica
Continente #
NA - Nord America 3.207
EU - Europa 1.898
AS - Asia 447
AF - Africa 95
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 5.658
Nazione #
US - Stati Uniti d'America 3.104
IT - Italia 897
CN - Cina 380
NL - Olanda 376
IE - Irlanda 162
DE - Germania 143
FI - Finlandia 129
CA - Canada 101
CI - Costa d'Avorio 84
UA - Ucraina 61
GB - Regno Unito 43
IN - India 29
FR - Francia 28
SE - Svezia 24
CH - Svizzera 21
SG - Singapore 12
VN - Vietnam 11
EG - Egitto 8
BR - Brasile 5
EU - Europa 4
TR - Turchia 4
IR - Iran 3
BE - Belgio 2
JP - Giappone 2
MA - Marocco 2
MK - Macedonia 2
MX - Messico 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
HR - Croazia 1
ID - Indonesia 1
KZ - Kazakistan 1
LT - Lituania 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 5.658
Città #
Chandler 608
Amsterdam 364
Naples 288
Ashburn 272
Millbury 240
Des Moines 145
Princeton 136
Nanjing 126
Napoli 123
Boston 108
Ottawa 88
Lawrence 82
Beijing 75
Wilmington 56
Nanchang 41
Jacksonville 36
Krefeld 32
Rome 30
Shenyang 27
Hebei 26
Houston 22
Seattle 22
Washington 22
Jiaxing 21
Tianjin 18
Basel 17
Dublin 16
Los Angeles 16
Kronberg 15
Milan 15
Ann Arbor 13
Caserta 13
Changsha 13
Norwalk 13
Pune 13
Pozzuoli 11
Indiana 9
Boardman 8
Bologna 8
Dong Ket 8
Lappeenranta 8
Pomigliano D'arco 8
Boise 7
Fisciano 7
Formia 7
Singapore 7
Council Bluffs 6
Redwood City 6
Woodbridge 6
Casalnuovo Di Napoli 5
Falls Church 5
Guangzhou 5
Hangzhou 5
Latina 5
Cairo 4
Castellammare di Stabia 4
Chicago 4
Fremont 4
Jinan 4
London 4
Padova 4
Qualiano 4
Richmond 4
Salerno 4
Sorrento 4
Torre del Greco 4
Agropoli 3
Aversa 3
Bari 3
Brescia 3
Campagna 3
Cologno Monzese 3
Dung 3
Frankfurt am Main 3
Geneva 3
Hanover 3
Helsinki 3
Lanzhou 3
Mariglianella 3
Montalbano Jonico 3
Mumbai 3
New York 3
Richland 3
San Giorgio A Cremano 3
Serra 3
Shenzhen 3
Torre Annunziata 3
Alcamo 2
Caivano 2
Caravaggio 2
Casablanca 2
Castellammare Di Stabia 2
Cava de' Tirreni 2
Edinburgh 2
Gualtieri 2
Maricopa 2
Marigliano 2
Mira 2
Montescaglioso 2
Mountain View 2
Totale 3.420
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 129
Hemolytic anemia during pegylated interferon alpha 2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. A case report 71
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 56
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 55
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 55
HIV and hepatitis C virus: facts and controversies 51
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 51
Infezione da cytomegalovirus 51
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 50
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 49
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 47
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer? 47
Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 46
A SIMPLE NONINVASIVE SCORE PREDICTS GASTROESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS. 45
Rara e grave manifestazione dell’infezione da HHV-6: la sindrome DRESS. 45
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 45
Asunaprevir for hepatitis C: A safety evaluation 45
Human Platelet Antigen 3 Genotype Is An Independent Predictor of Platelet Count In Patients With Chronic Hepatitis C 44
[HBV and pregnancy]. 43
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 43
Does compulsory vaccination limit personal freedom? Ethical issues 43
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. 43
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 42
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 41
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 41
Antibiotic prophylaxis and risk of infections in thyroid surgery: Results from a national study (UEC - Italian Endocrine Surgery Units Association) 40
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 40
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 40
Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice 39
Blood letting therapy in HCV-related iron overload - Part 1: Evaluation of clinical, hematological and hepatic parameters 38
Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy 38
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 38
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals 38
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 37
ABT-450: A novel protease inhibitor for the treatment of hepatitis C virus infection 37
Il Virus varicella Zoster 37
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 37
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus. 36
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 36
Beclabuvir for the treatment of hepatitis C 35
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 35
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 35
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 35
Compromissione cognitiva subclinica in pazienti HCV-positivi 34
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 34
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 34
Current evidence on the management of hepatitis B in pregnancy 33
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 33
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 33
Direct acting antiviral agents and hepatocellular carcinoma development: Don't take it for granted 33
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 32
A CASE OF PEGYLATED INTERFERON ALPHA-RELATED DIABETIC KETOACIDOSIS: CAN THIS COMPLICATION BE AVOIDED? 32
Blood letting therapy in HCV-related iron overload - Part 2: Evaluation of HFE genetic mutation, HCV genotype and viral load 32
Noninvasive prediction of oesophageal varices: As simple as blood count? 32
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 32
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 32
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 31
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 31
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 31
A pill a day keeps HCV away 31
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 31
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 31
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 31
Chest CT in COVID-19 patients: structured vs conventional reporting 31
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 31
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves 30
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 30
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 30
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 30
DNA detection of herpetic viruses in dried blood spots in children with autism spectrum disorders 30
Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves? 30
Epstein-Barr virus 29
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 29
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 29
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 29
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 29
The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism 29
A transient increase in the serum ancas in patients with sars-cov-2 infection: A signal of subclinical vasculitis or an epiphenomenon with no clinical manifestations? a pilot study 29
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 28
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis 28
Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis 28
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 28
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 28
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. 27
Febbre di origine sconosciuta (FUO): nostra casistica 27
Uno score non invasivo può predire la presenza di varici gastroesofagee nei pazienti con epatopatia cronica virale. 27
Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial. 27
Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy 27
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 27
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens 27
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 27
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 27
Cytometric analysis of patients with COVID-19: what is changed in the second wave? 27
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 27
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 27
Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. 26
A case of paracoccidioidomycosis: Experience with long-term therapy 26
Secondary hemosiderosis, iron depletion and hepatitis C viral load 26
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 26
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 26
Totale 3.631
Categoria #
all - tutte 27.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201937 0 0 0 0 0 0 0 0 0 0 4 33
2019/2020521 233 14 14 10 50 8 5 11 6 42 79 49
2020/2021341 27 12 22 17 57 40 44 13 42 27 21 19
2021/20221.207 15 8 17 11 8 38 20 45 162 75 270 538
2022/20232.044 227 113 52 98 206 205 45 276 311 367 86 58
2023/20241.168 69 218 279 91 90 173 40 149 32 27 0 0
Totale 6.117